370 related articles for article (PubMed ID: 33999469)
1. Utrophin modulator drugs as potential therapies for Duchenne and Becker muscular dystrophies.
Soblechero-Martín P; López-Martínez A; de la Puente-Ovejero L; Vallejo-Illarramendi A; Arechavala-Gomeza V
Neuropathol Appl Neurobiol; 2021 Oct; 47(6):711-723. PubMed ID: 33999469
[TBL] [Abstract][Full Text] [Related]
2. Correlation of Utrophin Levels with the Dystrophin Protein Complex and Muscle Fibre Regeneration in Duchenne and Becker Muscular Dystrophy Muscle Biopsies.
Janghra N; Morgan JE; Sewry CA; Wilson FX; Davies KE; Muntoni F; Tinsley J
PLoS One; 2016; 11(3):e0150818. PubMed ID: 26974331
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic strategies for Duchenne and Becker dystrophies.
Voisin V; de la Porte S
Int Rev Cytol; 2004; 240():1-30. PubMed ID: 15548414
[TBL] [Abstract][Full Text] [Related]
4. Utrophin upregulation in Duchenne muscular dystrophy.
Hirst RC; McCullagh KJ; Davies KE
Acta Myol; 2005 Dec; 24(3):209-16. PubMed ID: 16629055
[TBL] [Abstract][Full Text] [Related]
5. Utrophin upregulation for treating Duchenne or Becker muscular dystrophy: how close are we?
Miura P; Jasmin BJ
Trends Mol Med; 2006 Mar; 12(3):122-9. PubMed ID: 16443393
[TBL] [Abstract][Full Text] [Related]
6. The potential of utrophin and dystrophin combination therapies for Duchenne muscular dystrophy.
Guiraud S; Edwards B; Babbs A; Squire SE; Berg A; Moir L; Wood MJ; Davies KE
Hum Mol Genet; 2019 Jul; 28(13):2189-2200. PubMed ID: 30990876
[TBL] [Abstract][Full Text] [Related]
7. The X-linked Becker muscular dystrophy (bmx) mouse models Becker muscular dystrophy via deletion of murine dystrophin exons 45-47.
Heier CR; McCormack NM; Tully CB; Novak JS; Newell-Stamper BL; Russell AJ; Fiorillo AA
J Cachexia Sarcopenia Muscle; 2023 Apr; 14(2):940-954. PubMed ID: 36628607
[TBL] [Abstract][Full Text] [Related]
8. Protein-Anchoring Therapy of Biglycan for Mdx Mouse Model of Duchenne Muscular Dystrophy.
Ito M; Ehara Y; Li J; Inada K; Ohno K
Hum Gene Ther; 2017 May; 28(5):428-436. PubMed ID: 27485975
[TBL] [Abstract][Full Text] [Related]
9. Utility of dystrophin and utrophin staining in childhood muscular dystrophy.
Sundaram C; Vydehi B; Meena K; Murthy J
Indian J Pathol Microbiol; 2004 Jul; 47(3):367-9. PubMed ID: 16295426
[TBL] [Abstract][Full Text] [Related]
10. Sarcospan integration into laminin-binding adhesion complexes that ameliorate muscular dystrophy requires utrophin and α7 integrin.
Marshall JL; Oh J; Chou E; Lee JA; Holmberg J; Burkin DJ; Crosbie-Watson RH
Hum Mol Genet; 2015 Apr; 24(7):2011-22. PubMed ID: 25504048
[TBL] [Abstract][Full Text] [Related]
11. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
[TBL] [Abstract][Full Text] [Related]
12. Naturally occurring utrophin correlates with disease severity in Duchenne muscular dystrophy.
Kleopa KA; Drousiotou A; Mavrikiou E; Ormiston A; Kyriakides T
Hum Mol Genet; 2006 May; 15(10):1623-8. PubMed ID: 16595608
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide and l-arginine cause an accumulation of utrophin at the sarcolemma: a possible compensation for dystrophin loss in Duchenne muscular dystrophy.
Chaubourt E; Fossier P; Baux G; Leprince C; Israël M; De La Porte S
Neurobiol Dis; 1999 Dec; 6(6):499-507. PubMed ID: 10600405
[TBL] [Abstract][Full Text] [Related]
14. Second-generation compound for the modulation of utrophin in the therapy of DMD.
Guiraud S; Squire SE; Edwards B; Chen H; Burns DT; Shah N; Babbs A; Davies SG; Wynne GM; Russell AJ; Elsey D; Wilson FX; Tinsley JM; Davies KE
Hum Mol Genet; 2015 Aug; 24(15):4212-24. PubMed ID: 25935002
[TBL] [Abstract][Full Text] [Related]
15. Dystrophin-associated protein abnormalities in dystrophin-deficient muscle fibers from symptomatic and asymptomatic Duchenne/Becker muscular dystrophy carriers.
Di Blasi C; Morandi L; Barresi R; Blasevich F; Cornelio F; Mora M
Acta Neuropathol; 1996 Oct; 92(4):369-77. PubMed ID: 8891069
[TBL] [Abstract][Full Text] [Related]
16. A and B utrophin in human muscle and sarcolemmal A-utrophin associated with tumours.
Sewry CA; Nowak KJ; Ehmsen JT; Davies KE
Neuromuscul Disord; 2005 Nov; 15(11):779-85. PubMed ID: 16198105
[TBL] [Abstract][Full Text] [Related]
17. CT-GalNAc transferase overexpression in adult mice is associated with extrasynaptic utrophin in skeletal muscle fibres.
Durko M; Allen C; Nalbantoglu J; Karpati G
J Muscle Res Cell Motil; 2010 Sep; 31(3):181-93. PubMed ID: 20706865
[TBL] [Abstract][Full Text] [Related]
18. Stabilization of the cardiac sarcolemma by sarcospan rescues DMD-associated cardiomyopathy.
Parvatiyar MS; Brownstein AJ; Kanashiro-Takeuchi RM; Collado JR; Dieseldorff Jones KM; Gopal J; Hammond KG; Marshall JL; Ferrel A; Beedle AM; Chamberlain JS; Renato Pinto J; Crosbie RH
JCI Insight; 2019 Apr; 5(11):. PubMed ID: 31039133
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity relationships of 2-pyrimidinecarbohydrazides as utrophin modulators for the potential treatment of Duchenne muscular dystrophy.
Chatzopoulou M; Conole D; Emer E; Rowley JA; Willis NJ; Squire SE; Gill B; Brough S; Wilson FX; Wynne GM; Davies SG; Davies KE; Russell AJ
Bioorg Med Chem; 2022 Sep; 69():116812. PubMed ID: 35772287
[TBL] [Abstract][Full Text] [Related]
20. The abnormal expression of utrophin in Duchenne and Becker muscular dystrophy is age related.
Taylor J; Muntoni F; Dubowitz V; Sewry CA
Neuropathol Appl Neurobiol; 1997 Oct; 23(5):399-405. PubMed ID: 9364465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
